Skip to main content

Table 1 Summary table of baseline characteristics across BMI groups

From: Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases

Baseline characteristics

BMI < 25 (n = 143)

BMI 25–30

(n = 210)

BMI > 30

(n = 207)

All

(n = 560)

Age (years): median (IQR)

48.1 (33.0–66.6)

55.7 (42.0–66.5)

55.0 (45.5–66.1)

54.8 (41.1–66.2)

Male (%)

61.6

72.0

63.3

66.1

BMI (kg/m2): median (IQR)

22.5 (20.9–23.8)

27.2 (26.0–28.6)

33.7 (31.6–36.8)

28.2 (24.9–32.1)

Systolic blood pressure (mmHg)

141 (23)

144 (22)

147 (21)

144 (22)

Diastolic Blood Pressure (mmHg)

75 (9)

80 (11)

82 (11)

80 (11)

eGFR (ml/min/1.73m2)

56 (38)

47 (31)

52 (34)

51 (34)

uPCR (mg/mmol): median (IQR)

318 (142–592)

317 (155–717)

400 (155–776)

337 (151–714)

Died during follow up: n(%)

40 (28.0)

50 (23.8)

43 (20.8)

133 (23.8)

RRT during follow up: n(%)

47 (32.9)

58 (27.6)

56 (27.1)

161 (28.9)

CKD 5 during follow up: n(%)

55 (38.5)

81 (38.6)

79 (38.2)

215 (38.4)

CKD 5 or RRT during follow up: n(%)

60 (42.0)

88 (41.9)

82 (39.6)

230 (41.1)

SIMD quintile: median (IQR)

2 (1–3)

2 (1–3)

2 (1–3)

2 (1–3)

  1. BMI Body Mass Index (kg/m2), uPCR Urinary Protein Creatinine Ratio, eGFR estimated glomerular filtration rate, RRT Renal Replacement Therapy, CKD Chronic Kidney Disease, SIMD Scottish Index of Multiple Deprivation, All data are mean (standard deviation) unless otherwise indicated